GW & Wade’s iShares MSCI EAFE Min Vol Factor ETF EFAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.15M Buy
16,562
+5,212
+46% +$345K 0.04% 213
2023
Q3
$740K Buy
11,350
+498
+5% +$33.5K 0.03% 242
2023
Q2
$733K Buy
+10,852
New +$748K 0.03% 242
2022
Q4
Sell
-7,055
Closed -$402K 389
2022
Q3
$402K Sell
7,055
-1,962
-22% -$123K 0.02% 269
2022
Q2
$571K Sell
9,017
-181
-2% -$12.2K 0.03% 237
2022
Q1
$664K Sell
9,198
-245
-3% -$17.8K 0.03% 219
2021
Q4
$725K Sell
9,443
-5,705
-38% -$435K 0.03% 216
2021
Q3
$1.14M Buy
15,148
+425
+3% +$33K 0.05% 177
2021
Q2
$1.11M Buy
14,723
+2,050
+16% +$154K 0.05% 174
2021
Q1
$925K Buy
12,673
+7,064
+126% +$518K 0.05% 166
2020
Q4
$412K Buy
+5,609
New +$395K 0.03% 208
2019
Q1
Sell
-5,355
Closed -$357K 233
2018
Q4
$357K Buy
5,355
+1,460
+37% +$100K 0.04% 161
2018
Q3
$284K Hold
3,895
0.03% 197
2018
Q2
$277K Hold
3,895
0.03% 198
2018
Q1
$287K Buy
+3,895
New +$287K 0.03% 184

Other funds holding EFAV

GW & Wade's EFAV Position: Q4 2023 in Review

GW & Wade increased its iShares MSCI EAFE Min Vol Factor ETF (EFAV) stake by 46% in Q4 2023, buying an estimated $345K and bringing the position to 16,562 shares worth $1.15M. The position accounts for 0.04% of the portfolio, ranked #213.

GW & Wade first reported a position in EFAV in Q1 2018 and has held it in 15 quarters since. 485 funds tracked by Wall St. Rank hold EFAV as of Q4 2023.

  • GW & Wade held 16,562 shares of iShares MSCI EAFE Min Vol Factor ETF worth $1.15M as of Q4 2023.
  • GW & Wade bought 5,212 iShares MSCI EAFE Min Vol Factor ETF shares in Q4 2023, an estimated $345K.
  • iShares MSCI EAFE Min Vol Factor ETF made up 0.04% of GW & Wade's portfolio in Q4 2023, its #213 holding.
  • GW & Wade first reported a position in iShares MSCI EAFE Min Vol Factor ETF in Q1 2018 and has held it in 15 quarters since.
  • 485 funds tracked by Wall St. Rank held iShares MSCI EAFE Min Vol Factor ETF as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.